Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avita Medical, Inc. - Common Stock (NQ:RCEL)

7.990 +3.240 (+68.22%)
Streaming Delayed Price Updated: 2:26 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Announce Second Quarter 2026 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Reports First Quarter 2026 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Names Cary Vance as Chief Executive Officer
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Announce First Quarter 2026 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc. - RCEL
From Pomerantz LLP
Via GlobeNewswire
News headline image
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
From AVITA Medical
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
AVITA Medical Announces Changes to its Board of Directors
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
From AVITA Medical
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA® Medical Reports Third Quarter 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
Global evidence and real-world data demonstrate the clinical, operational, and economic impact of AVITA Medical’s RECELL System across wound types and patient populations 
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Announce Third Quarter 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation – RCEL
From The Rosen Law Firm, P.A.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.